{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:25:50Z","timestamp":1790767550679,"version":"4.1.0"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2025A03J1082"],"award-info":[{"award-number":["2025A03J1082"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515010807"],"award-info":[{"award-number":["2025A1515010807"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.intimp.2025.114896","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:08:31Z","timestamp":1747901311000},"page":"114896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Immunoregulatory effects of traditional Chinese medicine and its ingredients on psoriasis"],"prefix":"10.1016","volume":"159","author":[{"given":"Wei","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huazhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiding","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114896_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.743180","article-title":"The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study","volume":"8","author":"Damiani","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0010","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jaad.2020.11.039","article-title":"Incidence of psoriasis among adults in the United States: a sex- and age-adjusted population analysis","volume":"84","author":"Burshtein","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0015","article-title":"Global psoriasis atlas, national, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2025.114896_bb0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2020.04.139","article-title":"The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 To 2017: a systematic analysis from the global burden of disease study 2017","volume":"84","author":"Mehrmal","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/bjd.18798","article-title":"A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasis","volume":"183","author":"Villacorta","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00403-024-02846-z","article-title":"Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030","volume":"316","author":"Wang","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.intimp.2025.114896_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122991","article-title":"Advances in psoriasis research: from pathogenesis to therapeutics","volume":"355","author":"Sugumaran","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.114896_bb0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/bjd\/ljac089","article-title":"Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III\/IIIb trials","volume":"188","author":"Kokolakis","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1056\/NEJMoa2308713","article-title":"An Oral Interleukin-23-receptor antagonist peptide for plaque psoriasis","volume":"390","author":"Bissonnette","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2024.10.076","article-title":"FRONTIER-2: a phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis","volume":"92","author":"Ferris","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40265-023-01988-0","article-title":"Spesolimab for the treatment of generalized pustular psoriasis","volume":"84","author":"Bernardo","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2025.114896_bb0060","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114896_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103530","article-title":"Formation and clinical effects of anti-drug antibodies against biologics in psoriasis treatment: an analysis of current evidence","volume":"23","author":"Sun","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2025.114896_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/bjd.19244","article-title":"Meta-analysis results do not reflect the real safety of biologics in psoriasis","volume":"184","author":"Afach","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13020-021-00550-y","article-title":"A review of Chinese medicine for the treatment of psoriasis: principles, methods and analysis","volume":"16","author":"Su","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0080","first-page":"296","article-title":"Efficacy and safety of Liangxue Jiedu decoction for the treatment of progressive psoriasis vulgaris: a multicenter, randomized, controlled study","volume":"40","author":"Sun","year":"2020","journal-title":"J. Tradit. Chin. Med. Chung Tsa Chih Ying Wen Pan"},{"key":"10.1016\/j.intimp.2025.114896_bb0085","first-page":"863","article-title":"Effectiveness of Xiaoyin Jiedu granules in the treatment of psoriasis vulgaris in patients with blood-heat symptom patterns in terms of traditional Chinese medicine","volume":"40","author":"Chen","year":"2020","journal-title":"J. Tradit. Chin. Med. Chung Tsa Chih Ying Wen Pan"},{"key":"10.1016\/j.intimp.2025.114896_bb0090","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031784","article-title":"Liangxue Jiedu Runzhi ointment in the treatment of mild and moderate psoriasis with blood-heat syndrome: a double-blind randomized controlled trial","volume":"101","author":"Qiu","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.intimp.2025.114896_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118166","article-title":"Chinese herbal medicine bath therapy for psoriasis vulgaris using topical calcipotriol as the comparator: a systematic review with meta-analysis and association rule analysis","volume":"330","author":"Wang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0100","article-title":"Adding Chinese herbal medicine bath therapy to conventional therapies for psoriasis vulgaris: a systematic review with meta-analysis of randomised controlled trials","volume":"128","author":"Wang","year":"2024","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.intimp.2025.114896_bb0105","doi-asserted-by":"crossref","first-page":"2355261","DOI":"10.1080\/09546634.2024.2355261","article-title":"Adjunctive Chinese medicine therapy reduces relapse of psoriasis vulgaris after discontinuation of biologics: a prospective registry-based cohort study","volume":"35","author":"Huang","year":"2024","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.intimp.2025.114896_bb0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40257-015-0128-6","article-title":"Complementary and alternative medicine for psoriasis: what the dermatologist needs to know","volume":"16","author":"Talbott","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115275","article-title":"Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis","volume":"294","author":"Li","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13020-024-00907-z","article-title":"Traditional Chinese medicine Shi-bi-Man ameliorates psoriasis via inhibiting IL-23\/Th17 axis and CXCL16-mediated endothelial activation","volume":"19","author":"Zhang","year":"2024","journal-title":"Chin. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114571","article-title":"Deciphering the mechanism of Fang-Ji-Di-Huang-decoction in ameliorating psoriasis-like skin inflammation via the inhibition of IL-23\/Th17 cell axis","volume":"281","author":"Song","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0130","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1111\/bph.17349","article-title":"Oroxylin a attenuates psoriasiform skin inflammation by direct targeting p62 (sequestosome 1) via suppressing M1 macrophage polarization","volume":"181","author":"Ma","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1084\/jem.20080129","article-title":"Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment","volume":"206","author":"Albanesi","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0140","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.114896_bb0145","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"Ganguly","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0150","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jid.2017.09.052","article-title":"RNase 7 strongly promotes TLR9-mediated DNA sensing by human Plasmacytoid dendritic cells","volume":"138","author":"Kopfnagel","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0160","doi-asserted-by":"crossref","first-page":"10723","DOI":"10.1073\/pnas.1307569110","article-title":"Langerinneg conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice","volume":"110","author":"Wohn","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.114896_bb0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev-immunol-051116-052215","article-title":"Antigen-presenting cells in the skin","volume":"35","author":"Sw","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jdermsci.2018.11.007","article-title":"Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production","volume":"93","author":"Nakajima","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2025.114896_bb0175","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/jid.2014.98","article-title":"IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing \u03b3\u03b4 T cells","volume":"134","author":"Yoshiki","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941071","article-title":"Dendritic cells and macrophages in the pathogenesis of psoriasis","volume":"13","author":"Kamata","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0185","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.immuni.2021.08.012","article-title":"Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation","volume":"54","author":"Liu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114896_bb0190","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/s41423-022-00940-8","article-title":"The epidermal immune microenvironment plays a dominant role in psoriasis development, as revealed by mass cytometry","volume":"19","author":"Zhou","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0195","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3892\/ijmm.2017.2930","article-title":"Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice by inhibiting the maturation and activation of dendritic cells","volume":"39","author":"Meng","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0200","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.intimp.2018.01.044","article-title":"Diarylheptanoid from rhizomes of Curcuma kwangsiensis (DCK) inhibited imiquimod-induced dendritic cells activation and Th1\/Th17 differentiation","volume":"56","author":"Liu","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0205","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.apsb.2021.07.019","article-title":"Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment","volume":"12","author":"Xi","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.114896_bb0210","article-title":"Celastrol gel ameliorates imiquimod-induced psoriasis-like dermatitis in mice by targeting Langerhans cells","volume":"147","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.intimp.2025.114896_bb0215","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/jcmm.17184","article-title":"Topical astilbin ameliorates imiquimod-induced psoriasis-like skin lesions in SKH-1 mice via suppression dendritic cell-Th17 inflammation axis","volume":"26","author":"Xu","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0220","article-title":"Jingfang granules exert anti-psoriasis effect by targeting MAPK-mediated dendritic cell maturation and PPAR\u03b3-mediated keratinocytes cell cycle progression in vitro and in vivo","volume":"117","author":"Xu","year":"2023","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.intimp.2025.114896_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.3977","article-title":"Yinxieling decoction ameliorates psoriasis by regulating the differentiation and functions of Langerhans cells via the TGF-\u03b21\/PU.1\/IL-23 signal axis","volume":"42","author":"Li","year":"2024","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.intimp.2025.114896_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118825","article-title":"Metabolic reprogramming and AMPK activation: key players in the therapeutic effects of cooling blood and Detoxicating Formular on psoriasis","volume":"337","author":"Wang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jdermsci.2018.01.005","article-title":"Up-regulated expression of CD86 on circulating intermediate monocytes correlated with disease severity in psoriasis","volume":"90","author":"Nguyen","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2025.114896_bb0240","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/path.4786","article-title":"Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes","volume":"240","author":"Leite Dantas","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2025.114896_bb0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00403-021-02207-0","article-title":"Macrophages in dermatology: pathogenic roles and targeted therapeutics","volume":"314","author":"Kuraitis","year":"2022","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.intimp.2025.114896_bb0250","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1172\/JCI27180","article-title":"Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation","volume":"116","author":"Wang","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.114896_bb0255","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/jid.2010.165","article-title":"A subpopulation of CD163-positive macrophages is classically activated in psoriasis","volume":"130","author":"Fuentes-Duculan","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdermsci.2009.01.003","article-title":"Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis","volume":"54","author":"Yawalkar","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2025.114896_bb0265","doi-asserted-by":"crossref","unstructured":"Y. Hou, L. Zhu, H. Tian, H.-X. Sun, R. Wang, L. Zhang, Y. Zhao, IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis, Protein Cell 9 (2018) 1027\u20131038. doi: https:\/\/doi.org\/10.1007\/s13238-018-0505-z.","DOI":"10.1007\/s13238-018-0505-z"},{"key":"10.1016\/j.intimp.2025.114896_bb0270","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/s41598-019-41655-7","article-title":"Monocytes\/macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114896_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154951","article-title":"EFLA 945 restricts AIM2 inflammasome activation by preventing DNA entry for psoriasis treatment","volume":"127","author":"Chung","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2025.114896_bb0280","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.2147\/JIR.S416417","article-title":"Resveratrol ameliorates Imiquimod-induced psoriasis-like mouse model via reducing macrophage infiltration and inhibiting glycolysis","volume":"16","author":"Wang","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2025.114896_bb0285","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1007\/s00210-024-03166-9","article-title":"Tanshinol ameliorates imiquimod-induced psoriasis by inhibiting M1 macrophage polarization through suppression of the notch signaling pathway, Naunyn. Schmiedebergs","volume":"397","author":"Liu","year":"2024","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112183","article-title":"Cornuside alleviates psoriasis-like skin lesions in mice by relieving inflammatory effects","volume":"134","author":"Yan","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0295","article-title":"Therapeutic efficacy of Scutellaria baicalensis Georgi against psoriasis-like lesions via regulating the responses of keratinocyte and macrophage","volume":"155","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.intimp.2025.114896_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117231","article-title":"PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization","volume":"243","author":"Li","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.114896_bb0305","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.114896_bb0310","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114896_bb0315","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jid.2015.12.036","article-title":"Increased, but functionally impaired, CD14(+) HLA-DR(\u2212\/low) myeloid-derived suppressor cells in psoriasis: a mechanism of dysregulated T cells","volume":"136","author":"Soler","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0320","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.jid.2016.02.816","article-title":"Myeloid-derived suppressor cells in psoriasis are an expanded population exhibiting diverse T-cell-suppressor mechanisms","volume":"136","author":"Cao","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0325","article-title":"Acitretin promotes the differentiation of myeloid-derived suppressor cells in the treatment of psoriasis","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0330","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.3892\/mmr.2016.5685","article-title":"Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules","volume":"14","author":"Ilkovitch","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"198","key":"10.1016\/j.intimp.2025.114896_bb0335","first-page":"3897","article-title":"CXCL17 attenuates Imiquimod-induced psoriasis-like skin inflammation by recruiting myeloid-derived suppressor cells and regulatory T cells","volume":"1950","author":"Oka","year":"2017","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.intimp.2025.114896_bb0340","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12742","article-title":"Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice","volume":"89","author":"Kim","year":"2019","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106553","article-title":"Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis","volume":"86","author":"Park","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0350","doi-asserted-by":"crossref","first-page":"1091541","DOI":"10.3389\/fimmu.2023.1091541","article-title":"Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.563433","article-title":"Chinese medicine formula PSORI-CM02 alleviates psoriatic dermatitis via M-MDSCs and Th17 crosstalk","volume":"11","author":"Deng","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110710","article-title":"Targeting upregulation of the immunosuppressive activity of MDSCs with indirubin as a novel strategy to alleviate psoriasis","volume":"123","author":"Hou","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0365","article-title":"Ze-Qi-Tang formula inhibits MDSCs glycolysis through the down-regulation of p21\/Hif1\u03b1\/Glut1 signal in psoriatic-like mice","volume":"130","author":"Zhu","year":"2024","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.intimp.2025.114896_bb0370","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3389\/fimmu.2019.02376","article-title":"Neutrophils in psoriasis","volume":"10","author":"Chiang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2018.03.049","article-title":"Neutrophils and redox stress in the pathogenesis of autoimmune disease","volume":"125","author":"Glennon-Alty","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2025.114896_bb0380","article-title":"Priming and de-priming of neutrophil responses in vitro and in vivo","volume":"48","author":"Vogt","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.intimp.2025.114896_bb0385","first-page":"130","article-title":"Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells, redox rep. Commun","volume":"23","author":"Lai","year":"2018","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.intimp.2025.114896_bb0390","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jid.2018.11.021","article-title":"Neutrophil extracellular traps induce human Th17 cells: effect of psoriasis-associated TRAF3IP2 genotype","volume":"139","author":"Lambert","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0395","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2147\/DDDT.S194765","article-title":"Cathepsin G cleaves and activates IL-36\u03b3 and promotes the inflammation of psoriasis","volume":"13","author":"Guo","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2025.114896_bb0400","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3389\/fimmu.2018.01936","article-title":"Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: new biomarkers in PsA","volume":"9","author":"Frasca","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0405","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41467-019-13756-4","article-title":"Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis","volume":"11","author":"Herster","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.114896_bb0410","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1038\/s44319-024-00150-5","article-title":"naRNA-LL37 composite DAMPs define sterile NETs as self-propagating drivers of inflammation","volume":"25","author":"Bork","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.intimp.2025.114896_bb0415","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3389\/fimmu.2019.00746","article-title":"Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4\/IL-36R crosstalk","volume":"10","author":"Shao","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0420","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/exd.14711","article-title":"Neutrophil extracellular traps promote keratinocyte inflammation via AIM2 inflammasome and AIM2-XIAP in psoriasis","volume":"32","author":"Cao","year":"2023","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112246","article-title":"Kan-Lu-Hsiao-Tu-Tan, a traditional Chinese medicine formula, inhibits human neutrophil activation and ameliorates imiquimod-induced psoriasis-like skin inflammation","volume":"246","author":"Chiang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762829","article-title":"Astragalus mongholicus Bunge water extract exhibits anti-inflammatory effects in human neutrophils and alleviates Imiquimod-induced psoriasis-like skin inflammation in mice","volume":"12","author":"Cheng","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114596","article-title":"Randialic acid B and tomentosolic acid block formyl peptide receptor 1 in human neutrophils and attenuate psoriasis-like inflammation in vivo","volume":"190","author":"Korinek","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0440","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/ars.2019.7835","article-title":"Imperatorin alleviates Psoriasiform dermatitis by blocking neutrophil respiratory burst, adhesion, and chemotaxis through selective phosphodiesterase 4 inhibition","volume":"35","author":"Tsai","year":"2021","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2025.114896_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111824","article-title":"A therapeutic strategy of parthenolide in improving imiquimod-induced psoriasis-like skin inflammation targeting IL-36\/NETs through skin transdermal therapeutic system","volume":"131","author":"Zhan","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0450","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0455","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cytogfr.2010.10.006","article-title":"Signal transduction pathways and transcriptional regulation in Th17 cell differentiation","volume":"21","author":"Hirahara","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2025.114896_bb0460","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.114896_bb0465","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.637829","article-title":"Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview","volume":"12","author":"Schinocca","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0475","doi-asserted-by":"crossref","first-page":"eabi8823","DOI":"10.1126\/sciimmunol.abi8823","article-title":"TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy","volume":"6","author":"Gupta","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.intimp.2025.114896_bb0480","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.114896_bb0485","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdermsci.2009.01.003","article-title":"Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis","volume":"54","author":"Yawalkar","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2025.114896_bb0490","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40257-022-00722-y","article-title":"Drug survival of interleukin (IL)-17 and IL-23 inhibitors for the treatment of psoriasis: a retrospective multi-country, multicentric cohort study","volume":"23","author":"Torres","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0495","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaad.2020.07.085","article-title":"Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: a systematic review and meta-analysis","volume":"84","author":"Loft","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0500","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.intimp.2025.114896_bb0505","first-page":"3789","article-title":"Astilbin emulsion improves guinea pig lesions in a psoriasis-like model by suppressing IL-6 and IL-22 via p38 MAPK","volume":"17","author":"Yu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2025.114896_bb0510","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopha.2017.05.127","article-title":"Astilbin decreases proliferation and improves differentiation in HaCaT keratinocytes","volume":"93","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.intimp.2025.114896_bb0515","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40659-019-0255-2","article-title":"Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease","volume":"52","author":"Wang","year":"2019","journal-title":"Biol. Res."},{"key":"10.1016\/j.intimp.2025.114896_bb0520","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.intimp.2015.12.035","article-title":"Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice via Jak3\/Stat3 signaling pathway","volume":"32","author":"Di","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0525","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.intimp.2019.05.030","article-title":"Betulinic acid suppresses Th17 response and ameliorates psoriasis-like murine skin inflammation","volume":"73","author":"Liu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0530","article-title":"Role of keratinocytes and immune cells in the anti-inflammatory effects of Tripterygium wilfordii Hook. f. in a murine model of psoriasis","volume":"77","author":"Ru","year":"2020","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.intimp.2025.114896_bb0535","doi-asserted-by":"crossref","first-page":"7468396","DOI":"10.1155\/2022\/7468396","article-title":"Triptolide inhibits Th17 response by upregulating microRNA-204-5p and suppressing STAT3 phosphorylation in psoriasis","volume":"2022","author":"He","year":"2022","journal-title":"Genet. Res."},{"key":"10.1016\/j.intimp.2025.114896_bb0540","article-title":"Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2\/STAT3 signal pathways","volume":"123","author":"Yuan","year":"2020","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.intimp.2025.114896_bb0545","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1002\/ptr.7155","article-title":"Rosmarinic acid protects mice from imiquimod induced psoriasis-like skin lesions by inhibiting the IL-23\/Th17 axis via regulating Jak2\/Stat3 signaling pathway","volume":"35","author":"Zhang","year":"2021","journal-title":"Phytother. Res. PTR"},{"key":"10.1016\/j.intimp.2025.114896_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114895","article-title":"Total withanolides ameliorates imiquimod-induced psoriasis-like skin inflammation","volume":"285","author":"Su","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0555","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ptr.8038","article-title":"Liquiritin targeting Th17 cells differentiation and abnormal proliferation of keratinocytes alleviates psoriasis via NF-\u03baB and AP-1 pathway","volume":"38","author":"Guo","year":"2024","journal-title":"Phytother. Res. PTR"},{"key":"10.1016\/j.intimp.2025.114896_bb0560","article-title":"Aloperine ameliorates IMQ-induced psoriasis by attenuating Th17 differentiation and facilitating their conversion to Treg","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114571","article-title":"Deciphering the mechanism of Fang-Ji-Di-Huang-decoction in ameliorating psoriasis-like skin inflammation via the inhibition of IL-23\/Th17 cell axis","volume":"281","author":"Song","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0570","article-title":"Xiaoyin Jiedu granules may alleviate psoriasis-like skin diseases in mice by regulating sphingosine 1-phosphate receptor expression and reducing Th17 cells","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2025.114896_bb0575","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0580","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"174","key":"10.1016\/j.intimp.2025.114896_bb0585","first-page":"164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"1950","author":"Sugiyama","year":"2005","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.intimp.2025.114896_bb0590","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0595","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jdermsci.2020.09.002","article-title":"A novel role of IL-17A in contributing to the impaired suppressive function of Tregs in psoriasis","volume":"101","author":"Liu","year":"2021","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2025.114896_bb0600","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.3389\/fimmu.2019.01865","article-title":"IL-21 induces an imbalance of Th17\/Treg cells in moderate-to-severe plaque psoriasis patients","volume":"10","author":"Shi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0605","doi-asserted-by":"crossref","first-page":"1233514","DOI":"10.3389\/fimmu.2023.1233514","article-title":"Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide","volume":"14","author":"Lee","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0610","doi-asserted-by":"crossref","first-page":"eadg6007","DOI":"10.1126\/sciadv.adg6007","article-title":"Adoptive Treg therapy with metabolic intervention via perforated microneedles ameliorates psoriasis syndrome","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2025.114896_bb0615","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3389\/fimmu.2017.01767","article-title":"PSORI-CM02 formula increases CD4+ Foxp3+ regulatory T cell frequency and ameliorates Imiquimod-induced psoriasis in mice","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0620","doi-asserted-by":"crossref","first-page":"1980456","DOI":"10.1155\/2020\/1980456","article-title":"The protective effects of 18\u03b2-Glycyrrhetinic acid on Imiquimod-induced psoriasis in mice via suppression of mTOR\/STAT3 signaling","volume":"2020","author":"Chen","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.intimp.2025.114896_bb0625","doi-asserted-by":"crossref","first-page":"48969","DOI":"10.1021\/acsami.4c06720","article-title":"Percutaneous delivery of Hederacoside C-loaded Nanoliposome gel alleviates Psoriasiform skin inflammation through the CCL17\/Treg Axis","volume":"16","author":"Chen","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.intimp.2025.114896_bb0630","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3389\/fimmu.2018.02092","article-title":"Esculetin ameliorates psoriasis-like skin disease in mice by inducing CD4+Foxp3+ regulatory T cells","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0635","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1073\/pnas.1508990112","article-title":"Inflammation induces dermal V\u03b34+ \u03b3\u03b4T17 memory-like cells that travel to distant skin and accelerate secondary IL-17\u2013driven responses","volume":"112","author":"Ram\u00edrez-Valle","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.114896_bb0640","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114896_bb0645","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A critical role of the IL-1\u03b2-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0650","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Ror\u03b3t+ innate lymphocytes and \u03b3\u03b4 T cells initiate psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.114896_bb0655","article-title":"Impact of obesity on the CCR6-CCL20 Axis in epidermal \u03b3\u03b4 T cells and IL-17A production in murine wound healing and psoriasis, BioRxiv Prepr","author":"Lawler","year":"2024","journal-title":"Serv. Biol."},{"key":"10.1016\/j.intimp.2025.114896_bb0660","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1073\/pnas.1704958114","article-title":"Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23\u2013dependent murine model","volume":"114","author":"Getschman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.114896_bb0665","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1073\/pnas.1704958114","article-title":"Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23\u2013dependent murine model","volume":"114","author":"Getschman","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.intimp.2025.114896_bb0670","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/eji.201546033","article-title":"\u0393\u03b4 T cells come to stay: innate skin memory in the Aldara model","volume":"45","author":"Prinz","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104136","article-title":"Dynamic trafficking patterns of IL-17-producing \u03b3\u03b4 T cells are linked to the recurrence of skin inflammation in psoriasis-like dermatitis","volume":"82","author":"Liu","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2025.114896_bb0680","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.molimm.2018.07.011","article-title":"Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing \u03b3\u03b4 T cells","volume":"101","author":"Xie","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107900","article-title":"Taxifolin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like mouse model via regulating cytoplasmic phospholipase A2 and PPAR-\u03b3 pathway","volume":"99","author":"Di","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0690","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11655-023-3599-y","article-title":"Inflammatory and immunomodulatory effects of Tripterygium wilfordii multiglycoside in mouse models of psoriasis keratinocytes","volume":"30","author":"Zhang","year":"2024","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0695","article-title":"Hyperforin ameliorates Imiquimod-induced psoriasis-like murine skin inflammation by modulating IL-17A-producing \u03b3\u03b4 T cells","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0700","article-title":"Xiao-Yin-Fang therapy alleviates psoriasis-like skin inflammation through suppressing \u03b3\u03b4T17 cell polarization","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0705","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41590-020-0607-7","article-title":"Developmental plasticity allows outside-in immune responses by resident memory T cells","volume":"21","author":"Fonseca","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0710","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41590-020-0723-4","article-title":"Tissue-resident memory CD8+ T cells shape local and systemic secondary T cell responses","volume":"21","author":"Behr","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0715","article-title":"Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy individuals","volume":"4","author":"Mm","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0720","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2023.11.017","article-title":"Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: appearances can be deceptive","volume":"153","author":"Migayron","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0725","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaci.2024.05.008","article-title":"Inflammatory memory in psoriasis: from remission to recurrence","volume":"154","author":"Francis","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"192","key":"10.1016\/j.intimp.2025.114896_bb0730","first-page":"3111","article-title":"Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis","volume":"1950","author":"Cheuk","year":"2014","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.intimp.2025.114896_bb0735","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines tissue-resident CD8+ T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114896_bb0740","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2019.06.002","article-title":"Significance of IL-17A-producing CD8+CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course","volume":"95","author":"Kurihara","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2025.114896_bb0745","doi-asserted-by":"crossref","first-page":"eabq3254","DOI":"10.1126\/sciimmunol.abq3254","article-title":"Local IL-23 is required for proliferation and retention of skin-resident memory TH17 cells","volume":"7","author":"Whitley","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0750","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature21379","article-title":"Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism","volume":"543","author":"Pan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.114896_bb0755","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jid.2023.04.021","article-title":"Resolved psoriasis with abundant oleic acid in stratum Corneum exhibits lower T-cell-driven IL-17 signature","volume":"143","author":"El Mahi","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0760","doi-asserted-by":"crossref","first-page":"10466","DOI":"10.7150\/thno.45211","article-title":"Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8+ T-cell memory in wild-type and humanized mice","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2025.114896_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115979","article-title":"Methotrexate and electrostimulation cooperate to alleviate the relapse of psoriasiform skin inflammation by suppressing memory T cells","volume":"219","author":"Chen","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118059","article-title":"Qinzhuliangxue mixture ameliorates psoriasis by restraining apoptosis in psoriasis via downregulating the MDA-5 pathway","volume":"328","author":"Wang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0775","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1303","article-title":"Wogonin ameliorates the proliferation, inflammatory response, and pyroptosis in keratinocytes via NOD-like receptor family pyrin domain containing 3\/Caspase-1\/Gasdermin-D pathway","volume":"12","author":"Ma","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.intimp.2025.114896_bb0780","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/CM9.0000000000003164","article-title":"Molecular and therapeutic landscape of ferroptosis in skin diseases","volume":"137","author":"Le","year":"2024","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.intimp.2025.114896_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116267","article-title":"Red clover (Trifolium pratense L.) extract inhibits ferroptotic cell death by modulating cellular iron homeostasis","volume":"308","author":"Won","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0790","article-title":"Celastrol regulates psoriatic inflammation and autophagy by targeting IL-17A","volume":"172","author":"Park","year":"2024","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.intimp.2025.114896_bb0795","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/s41467-023-37798-x","article-title":"Tenascin C+ papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.114896_bb0800","doi-asserted-by":"crossref","first-page":"eabq7991","DOI":"10.1126\/sciimmunol.abq7991","article-title":"Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems","volume":"8","author":"Castillo","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0805","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41467-023-39020-4","article-title":"Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.114896_bb0810","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41467-024-44994-w","article-title":"Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade","volume":"15","author":"Francis","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.114896_bb0815","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/bjd\/ljae205","article-title":"Fibroblasts with high matrix metalloproteinase 2 expression regulate CD8+ T-cell residency and inflammation via CD100 in psoriasis","volume":"191","author":"Dong","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0820","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjd.20940","article-title":"Antivascular endothelial growth factor-a therapy: a novel personalized treatment approach for psoriasis","volume":"186","author":"Luengas-Martinez","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0825","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13020-024-00907-z","article-title":"Traditional Chinese medicine Shi-bi-Man ameliorates psoriasis via inhibiting IL-23\/Th17 axis and CXCL16-mediated endothelial activation","volume":"19","author":"Zhang","year":"2024","journal-title":"Chin. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0830","article-title":"The anti-angiogenic effect of tryptanthrin is mediated by the inhibition of apelin promoter activity and shortened mRNA half-life in human vascular endothelial cells","volume":"58","author":"Chang","year":"2019","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.intimp.2025.114896_bb0835","article-title":"Anti-Angiogenic efficacy of PSORI-CM02 and the associated mechanism in psoriasis in vitro and in vivo","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114896_bb0840","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4678087","article-title":"Yangxue Jiedu Fang ameliorates psoriasis by regulating vascular regression via Survivin\/PI3K\/Akt pathway","volume":"2021","author":"Lv","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.intimp.2025.114896_bb0845","article-title":"Traditional Chinese medicine use among patients with psoriasis in Taiwan: a Nationwide population-based study, Evid.-based complement","volume":"2016","author":"Weng","year":"2016","journal-title":"Altern. Med. ECAM"},{"key":"10.1016\/j.intimp.2025.114896_bb0850","first-page":"1015","article-title":"Efficacy and safety of indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: a randomized, observer-blind, vehicle-controlled trial","volume":"21","author":"Lin","year":"2014","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.intimp.2025.114896_bb0855","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/bjd.15894","article-title":"Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial","volume":"178","author":"Lin","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2025.114896_bb0860","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2329261","article-title":"Evidence and potential mechanism of action of indigo naturalis and its active components in the treatment of psoriasis","volume":"56","author":"Wang","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115522","article-title":"Psoriasis treatment using indigo Naturalis: Progress and strategy","volume":"297","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114896_bb0870","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.21037\/apm-20-2575","article-title":"Comparison of PSORI-CM01 granules and Yinxieling tablets for patients with chronic plaque psoriasis: a pilot study for a randomized, double-blinded, double-dummy, multicentre trial","volume":"10","author":"Yao","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0875","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.286","article-title":"Add-on effect of PSORI-CM01 to topical calcipotriol for moderate psoriasis vulgaris: a multi-center, randomized, double-blind pilot study","volume":"11","author":"Parker","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0880","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014475","article-title":"Oral Chinese herbal medicine for psoriasis vulgaris: protocol for a randomised, double-blind, double-dummy, multicentre clinical trial","volume":"7","author":"Deng","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.intimp.2025.114896_bb0885","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13063-016-1272-x","article-title":"Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial","volume":"17","author":"Yao","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.intimp.2025.114896_bb0890","article-title":"Efficacy and safety of Tripterygium Wilfordii hook F on psoriasis vulgaris: a systematic review and Meta-analysis of randomized controlled trials, Evid.-based complement","volume":"2018","author":"Lv","year":"2018","journal-title":"Altern. Med. ECAM"},{"key":"10.1016\/j.intimp.2025.114896_bb0895","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11655-023-3737-y","article-title":"Total glucosides of Paeony regulate immune imbalance mediated by dermal mesenchymal stem cells in psoriasis mice","volume":"29","author":"Lei","year":"2023","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.intimp.2025.114896_bb0900","doi-asserted-by":"crossref","first-page":"2355261","DOI":"10.1080\/09546634.2024.2355261","article-title":"Adjunctive Chinese medicine therapy reduces relapse of psoriasis vulgaris after discontinuation of biologics: a prospective registry-based cohort study","volume":"35","author":"Huang","year":"2024","journal-title":"J. Dermatol. Treat."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925008860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925008860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:53:47Z","timestamp":1762552427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925008860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":180,"alternative-id":["S1567576925008860"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114896","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoregulatory effects of traditional Chinese medicine and its ingredients on psoriasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114896"}}